welcome
CNBC

CNBC

Health

Health

Roche and Zealand Pharma strike $5.3 billion deal for new obesity drug candidate

CNBC
Summary
Nutrition label

74% Informative

Swiss pharmaceutical giant Roche said Wednesday that it had struck a deal worth up to $5.3 billion to develop Zealand Pharma 's obesity drug candidate.

Shares of Zealand Pharma jumped as much as 29% shortly after the announcement, while Roche added 4.6% .

Deal will see the two companies co-develop and co-commercialize petrelintide as a standalone therapy.

VR Score

81

Informative language

86

Neutral language

42

Article tone

formal

Language

English

Language complexity

49

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links